Bank of Montreal Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Bank of Montreal şirketinin toplam varlıkları CA$1,400.5B ve toplam öz sermayesi CA$83.0B. Toplam mevduatlar CA$965.2B ve toplam krediler CA$673.2B olup 1.6% Faiz Marjı kazandırmaktadır. Şu anda toplam kredilerin 0.9% oranında olan kötü krediler için yeterli ödeneği yoktur. Nakit ve kısa vadeli yatırımlar CA$401.2B tutarındadır.

Anahtar bilgiler

16.9x

Varlık/özkaynak oranı

1.6%

Net faiz marjı

Toplam mevduat	CA$965.24b
Kredi/mevduat oranı	Uygun
Batık krediler	0.9%
Sorunlu krediler için ayrılan karşılık	Düşük
Cari oran	Düşük
Nakit ve eşdeğerleri	CA$401.18b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Bank of Montreal: Decent Dividend Yield, But Canada's Recession Fears Linger

Aug 15

Bank of Montreal: Decline In Net Interest Income Continues To Place Pressure On Earnings

May 30

Bank of Montreal: What Can We Expect?

May 24

Bank Of Montreal Q1: Higher Provision For Credit Losses And Rate Uncertainty Could Limit Growth

Feb 28

Bank of Montreal: Overvalued But Nice 4.5% Dividend Yield And Growth From Recent Takeover

Aug 02

Bank of Montreal: Non-Interest Income Headwinds Remain

May 28

Bank of Montreal implements fourth wage increase in two years

Feb 06

Bank of Montreal announces C$650M institutional NVCC preferred stock offering

Jan 24

Bank of Montreal gets regulatory approval to acquire Bank of the West

Jan 18

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Finansal Kurumlar Analizi

Varlık Seviyesi: BMO 'nin Varlıkların Öz Sermayeye Oranı ( 16.9 x) orta'dır.

Kötü Krediler İçin Ödenek: BMO düşük kötü krediler için ödeneke sahiptir ( 71 %).

Düşük Riskli Yükümlülükler: BMO 'un yükümlülüklerinin 73% 'i esas olarak düşük riskli finansman kaynaklarından oluşmaktadır.

Kredi Seviyesi: BMO Kredi/Varlık oranı açısından uygun bir seviyeye sahiptir ( 48% ).

Düşük Riskli Mevduatlar: BMO 'nin Kredi/Mevduat oranı ( 70% ) uygundur.

Kötü Kredilerin Seviyesi: BMO uygun düzeyde kötü krediler içeriyor ( 0.9 %).

Bank of Montreal Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Upcoming dividend of CA$1.55 per share

BMO Launches PaySmart Credit Card Installment Plan Feature in the U.S

BMO Appoints Kristin Milchanowski as Chief Artificial Intelligence and Data Officer

Third quarter dividend of CA$1.55 announced

Third quarter 2024 earnings: EPS misses analyst expectations

Bmo Financial Group Declares Quarterly Dividends on Common Shares, Payable on November 26, 2024

Bank of Montreal(TSX:BMO.PRT) dropped from S&P/TSX Preferred Share Index

Bank of Montreal: Decent Dividend Yield, But Canada's Recession Fears Linger

BMO Financial Group Launches Enhanced Premium Rewards Credit Card with Mastercard to Help Customers Make Real Financial Progress

Upcoming dividend of CA$1.55 per share

Second quarter dividend of CA$1.55 announced

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Bank of Montreal Declares Dividend for the Third Quarter of Fiscal Year 2024, Payable on August 27, 2024

Bank of Montreal: Decline In Net Interest Income Continues To Place Pressure On Earnings

Bank of Montreal(TSX:BMO.PRS) dropped from S&P/TSX Preferred Share Index

Bank of Montreal: What Can We Expect?

BMO Launches Greener Future Financing Program to Help U.S. Businesses Build Climate Resilient Operations

Upcoming dividend of CA$1.51 per share

Bank of Montreal Declares Dividend on Common Shares, Payable on May 28, 2024

Bank Of Montreal Q1: Higher Provision For Credit Losses And Rate Uncertainty Could Limit Growth

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of CA$1.51 per share at 4.7% yield

Bank of Montreal: Upgrade To Buy, +5% Dividend Yield And Attractive Valuation

Full year 2023 earnings: EPS misses analyst expectations

Bank of Montreal Increases Common Share Dividend, Payable on February 27, 2024

Bank of Montreal Is Reportedly Exploring Sale of RV Loan Portfolio

Upcoming dividend of CA$1.47 per share at 5.4% yield

Bank of Montreal: Drop In Trading Revenues Place Pressure On Growth

BMO Financial Group Announces Chief Executive Officer Changes

Bank of Montreal's 5% Yield: Value Opportunity?

Bank of Montreal to Report Q1, 2024 Results on Feb 27, 2024

Bank of Montreal Appoints Hazel Claxton to Its Board of Directors

Bank of Montreal: Its Direction Shows Promise

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Bank of Montreal, Annual General Meeting, Apr 16, 2024

Bank of Montreal: Overvalued But Nice 4.5% Dividend Yield And Growth From Recent Takeover

Upcoming dividend of CA$1.47 per share at 4.8% yield

Abu Dhabi Developmental Holding Company PJSC and Bank of Montreal entered into definitive agreements to acquire an unknown minority stake in Sagard and Great-West Lifeco Inc. has agreed to increase its existing minority stake.

Bank of Montreal: Non-Interest Income Headwinds Remain

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Bank of Montreal Declares Quarterly Dividend for the Third Quarter of Fiscal Year 2023, Payable on August 28, 2023

Upcoming dividend of CA$1.43 per share at 4.6% yield

Independent Director recently bought US$100k worth of stock

Independent Chairman of the Board recently bought US$1.6m worth of stock

First quarter 2023 earnings: EPS and revenues miss analyst expectations

BMO Financial Group Appoints Nadim Hirji as Group Head, BMO Commercial Banking, Effective March 1, 2023

Bank of Montreal implements fourth wage increase in two years

BMO Rolls Out Its Enhanced BMO Harris Business Platinum Rewards Mastercard

Bank of Montreal announces C$650M institutional NVCC preferred stock offering

Upcoming dividend of CA$1.43 per share

Bank of Montreal gets regulatory approval to acquire Bank of the West

Bank of Montreal to Report Q3, 2023 Results on Aug 29, 2023

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Finansal Kurumlar Analizi

Sağlıklı şirketleri keşfedin